Plasma membrane microdomains in aging and disease

Geriatrics and Gerontology International

Volumn 10, Issue SUPPL. 1, 2010, Pages

  Ohno Iwashita, Yoshiko ^a   Shimada, Yukiko ^a   Hayashi, Masami ^a   Inomata, Mitsushi ^a  

^a IWAKI MEISEI UNIVERSITY   (Japan)

Author keywords

Cholesterol; Lipid raft; Microdomain; Signal transduction

Indexed keywords

ABC TRANSPORTER A1; AEROLYSIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; BETA CYCLODEXTRIN; BETA SECRETASE; CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; CD36 ANTIGEN; CHOLERA TOXIN; CHOLESTEROL; CYTOLYSIN; FATTY ACID; GAMMA SECRETASE; GANGLIOSIDE; GANGLIOSIDE GM1; GANGLIOSIDE GM3; GLUCOSE TRANSPORTER 4; GLYCOSYLPHOSPHATIDYLINOSITOL; INSULIN RECEPTOR; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEMBRANE PROTEIN; SHIGA TOXIN; SPHINGOLIPID; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADIPOCYTE; AGING; ALZHEIMER DISEASE; ASTHMA; ATHEROSCLEROSIS; CAMPYLOBACTER JEJUNI; CAVEOLA; CELL AGING; CELL FUNCTION; CELL MEMBRANE; CHOLERA; CLOSTRIDIUM TETANI; DIABETES MELLITUS; EBOLA VIRUS; ENDOTHELIUM CELL; ENTEROVIRUS INFECTION; EPSTEIN BARR VIRUS INFECTION; ESCHERICHIA COLI INFECTION; EUKARYOTE; FIBROBLAST; FLUORESCENCE RESONANCE ENERGY TRANSFER; GAUCHER DISEASE; HEDGEHOG; HERPES SIMPLEX VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFLUENZA; LIFESTYLE; LIPID RAFT; MARBURG VIRUS; MUSCLE ATROPHY; MYCOBACTERIUM TUBERCULOSIS; NEOPLASM; NIEMANN PICK DISEASE; PARKINSON DISEASE; PLASMODIUM; POLYMERIZATION; PRION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; ROTAVIRUS INFECTION; SALMONELLA TYPHIMURIUM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SRC HOMOLOGY DOMAIN; SYSTEMIC LUPUS ERYTHEMATOSUS; TANGIER DISEASE; TETANUS; TOXOPLASMA GONDII; TRYPANOSOMA; TUBERCULOSIS; VIRUS INFECTION; CYTOLOGY; EUKARYOTIC CELL; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PLASMA; T LYMPHOCYTE;

AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; CAVEOLAE; CAVEOLIN 1; CELL AGING; DIABETES MELLITUS; EUKARYOTIC CELLS; HUMANS; MEMBRANE MICRODOMAINS; PLASMA; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; VIRUS DISEASES;

EID: 77954672564     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2010.00600.x     Document Type: Review

References (101)

1. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997, 387:569-572.
2. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000, 1:31-39.
3. Pike LJ. Rafts defined. J Lipid Res 2006, 47:1597-1598.
4. Brown DA, London E. Structure of detergent-resistant membrane domains: does phase separation occur in biological membranes? Biochem Biophys Res Commun 1997, 240:1-7.
5. Pike LJ. Lipid rafts: heterogeneity on the high seas. Biochem J 2004, 378:281-292.
6. Mayor S, Rao M. Rafts: scale-dependent, active lipid organization at the cell surface. Traffic 2004, 5:231-240.
7. Hirokawa K, Utsuyama M, Kasai M, Kurashima C. Aging and Immunity. Acta Pathol Jpn 1992, 42:537-548.
8. Yeo EJ, Park SC. Age-dependent agonist-specific dysregulation of membrane-mediated signal transduction: emergence of the gate theory of aging. Mech Ageing Dev 2002, 123:1563-1578.
9. Tamir A, Eisenbraun MD, Garcia GG, Miller RA. Age-dependent alterations in the assembly of signal transduction complexes at the site of T cell/APC interaction. J Immunol 2000, 165:1243-1251.
10. Larbi A, Douziech N, Dupuis G. Age-associated alterations in the recruitment of signal-transduction proteins to lipid rafts in human T lymphocytes. J Leukoc Biol 2004, 75:373-381.
11. Park WY, Park JS, Cho KA. Up-regulation of caveolin attenuates epidermal growth factor signalling in senescent cells. J Biol Chem 2000, 275:20847-20852.
12. Volonte D, Zhang K, Lisanti MP, Galbiati F. Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts. Mol Biol Cell 2002, 13:2502-2517.
13. Simons K, Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest 2002, 110:597-603.
14. Wolozin B. A fluid connection: cholesterol and Aβ. Proc Natl Acad Sci USA 2001, 98:5371-5373.
15. Kusumi A, Koyama-Honda I, Suzuki K. Molecular dynamics and interactions for creation of stimulation-induced stabilized rafts from small unstable steady-state rafts. Traffic 2004, 5:213-230.
16. Hayashi M, Shimada Y, Inomata M, Ohno-Iwashita Y. Detection of cholesterol-rich microdomains in the inner leaflet of the plasma membrane. Biochem Biophys Res Commun 2006, 351:713-718.
17. London E, Brown DA. Insolubility of lipids in triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). Biochim Biophys Acta 2000, 1508:182-195.
18. Brown DA, Rose JK. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 1992, 68:533-544.
19. Zajchowski LD, Robbins SM. Lipid rafts and little caves. Compartmentalized signaling in membrane microdomains. Eur J Biochem 2002, 269:737-752.
20. Rajendran L, Simons K. Lipid rafts and membrane dynamics. J Cell Sci 2005, 118:1099-1102.
21. Heijnen HFG, Van Lier M, Waaijenborg S. Concentration of rafts in platelet filopodia correlates with recruitment of c-Src and CD63 to these domains. J Thromb Haemost 2003, 1:1161-1173.
22. Gomez-Mouton C, Abad JL, Mira E. Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization. Proc Natl Acad Sci USA 2001, 98:9642-9647.
23. Shimada Y, Inomata M, Suzuki H, Hayashi M, Waheed AA, Ohno-Iwashita Y. Separation of a cholesterol-enriched microdomain involved in T-cell signal transduction. FEBS J 2005, 272:5454-5463.
24. Cohen AW, Hnasko R, Schubert W, Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol Rev 2004, 84:1341-1379.
25. Fra AM, Williamson E, Simons K, Parton RG. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc Natl Acad Sci USA 1995, 92:8655-8659.
26. Parton RG. Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae. J Histochem Cytochem 1994, 42:155-166.
27. Fivaz M, Abrami L, van der Goot FG. Landing on lipid rafts. Trends Cell Biol 1999, 9:212-213.
28. Yamaji A, Sekizawa Y, Emoto K. Lysenin, a novel sphingomyelin-specific binding protein. J Biol Chem 1998, 273:5300-5306.
29. Miller RG. The use and abuse of filipin to localize cholesterol in membranes. Cell Biol Int Rep 1984, 8:519-535.
30. Ohno-Iwashita Y, Shimada Y, Waheed AA. Perfringolysin O, a cholesterol-binding cytolysin, as a probe for lipid rafts. Anaerobe 2004, 10:125-134.
31. Ohno-Iwashita Y, Iwamoto M, Mitsui K, Ando S, Nagai Y. Protease-nicked theta-toxin of Clostridium perfringens, a new membrane probe with no cytolytic effect, reveals two classes of cholesterol as toxin-binding sites on sheep erythrocytes. Eur J Biochem 1988, 176:95-101.
32. Iwamoto M, Morita I, Fukuda M, Murota S, Ando S, Ohno-Iwashita Y. A biotinylated perfringolysin O derivative: a new probe for detection of cell surface cholesterol. Biochim Biophys Acta 1997, 1327:222-230.
33. Shimada Y, Maruya M, Iwashita S, Ohno-Iwashita Y. The C-terminal domain of perfringolysin O is an essential cholestereol-binding unit targeting to cholesterol-rich microdomains. Eur J Biochem 2002, 269:6195-6203.
34. Ohno-Iwashita Y, Iwamoto M, Ando S, Iwashita S. Effect of lipidic factors on membrane cholesterol topology - mode of binding of theta-toxin to cholesterol in liposomes. Biochim Biophys Acta 1992, 1109:81-90.
35. Waheed AA, Shimada Y, Heijinen HFG. Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts). Proc Natl Acad Sci USA 2001, 98:4926-4931.
36. Fujimoto T, Hayashi M, Iwamoto M, Ohno-Iwashita Y. Cross-linked plasmalemmal cholesterol is sequestered to caveolae: analysis with a new cytochemical probe. J Histochem Cytochem 1997, 45:1197-1205.
37. Inomata M, Shimada Y, Hayashi M, Kondo H, Ohno-Iwashita Y. Detachment-associated changes in lipid rafts of senescent human fibroblasts. Biochem Biophys Res Commun 2006, 343:489-495.
38. Möbius W, Ohno-Iwashita Y, van Donselaar EG. Immunoelectron microscopic localization of cholesterol using biotinylated and non-cytolytic perfringolysin O. J Histochem Cytochem 2002, 50:43-55.
39. Tani-ichi S, Maruyama K, Kondo N. Structure and funtion of lipid rafts in human activated T cells. Int Immunol 2005, 17:749-758.
40. Tashiro Y, Yamazaki T, Shimada Y, Ohno-Iwashita Y, Okamoto K. Axon-dominant localization of cell-surface cholesterol in cultured hippocampal neurons and its disappearance in Niemann-Pick type C model cells. Eur J Neurosci 2004, 20:2015-2021.
41. Ishii H, Mori T, Shiratsuchi A. Distinct localization of lipid rafts and externalized phosphatidylserine at the surface of apoptotic cells. Biochem Biophys Res Commun 2005, 327:94-99.
42. Koseki M, Hirano K, Masuda D. Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-alpha secretion in ABCa1-deficient macrophages. J Lipid Res 2007, 48:299-306.
43. Sugii S, Reid PC, Ohgami N. Biotinylated θ-toxin derivative as a probe to examine intracellular cholesterol-rich domains in normal and Niemann-Pick type C1 cells. J Lipid Res 2003, 44:1033-1041.
44. Wada S, Morishima-Kawashima M, Qi Y. Gamma-secretase activity is present in rafts but is not cholesterol-dependent. Biochemistry 2003, 42:13977-13986.
45. Sato SB, Ishii K, Makino A. Distribution and transport of cholesterol-rich membrane domains monitored by a membrane-impermeant fluorescent polyethylene glycol-derivatized cholesterol. J Biol Chem 2004, 279:23790-23796.
46. Jury EC, Kabouridis PS. T-lymphocyte signaling in systemic lupus erythematosus: a lipid raft perspective. Lupus 2004, 13:413-422.
47. Lusa S, Blom TS, Eskelinen E-L. Depletion of rafts in late endocytic membranes is controlled by NPC1-dependent recycling of cholesterol to the plasma membrane. J Cell Sci 2001, 114:1893-1900.
48. Sillence DJ, Platt FM. Storage diseases: new insights into sphingolipid functions. Trends Cell Biol 2003, 13:195-203.
49. Mattson MP. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
50. Riddell DR, Christie G, Hussain I, Dingwall C. Compartmentalization of β-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts. Curr Biol 2001, 11:1288-1293.
51. Lee S-J, Liyanage U, Bickel PE, Xia W, Lansbury PT, Kosik KS. A detergent-insoluble membrane compartment contains Aβ in vivo. Nat Med 1998, 4:730-734.
52. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 1998, 95:6460-6464.
53. Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10. Proc Natl Acad Sci USA 2001, 98:5815-5820.
54. Ehehalt R, Keller P, Haass C, Thiele C, Simons K. Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts. J Cell Biol 2003, 160:113-123.
55. Abad-Rodriguez J, Ledesma MD, Craessaerts K. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol 2004, 167:953-960.
56. Kaether C, Haass C. A lipid boundary separates APP and secretases and limits amyloid β-peptide generation. J Cell Biol 2004, 167:809-812.
57. Hayashi H, Kimura N, Yamaguchi H. A seed for Alzheimer amyloid in the brain. J Neurosci 2004, 24:4894-4902.
58. Kakio A, Nishimoto S, Yanagisawa K, Kozutsumi Y, Matsuzaki K. Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, an endogenous seed for Alzheimer amyloid. J Biol Chem 2001, 276:24985-24990.
59. Igbavboa U, Avdulov NA, Schroeder F, Wood WG. Increasing age alters transbilayer fluidity and cholesterol asymmetry in synaptic plasma membranes of mice. J Neurochem 1996, 66:1717-1725.
60. Frank PG, Marcel YL, Connelly MA. Stabilization of caveolin-1 by cellular cholesterol and scavenger receptor class B type I. Biochemistry 2002, 41:11931-11940.
61. Frank PG, Lee H, Park DS, Tandon NN, Scherer PE, Lisanti MP. Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arterioscler Thromb Vasc Biol 2004, 24:98-105.
62. Brooks-Wilson A, Marcil M, Clee SM. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999, 22:336-345.
63. Landry YD, Denis M, Nandi S, Bell S, Vaughan AM, Zha X. ATP-binding cassette transporter A-1 expression disrupts raft membrane microdomains through its ATPase-related functions. J Biol Chem 2006, 281:36091-36101.
64. Virkamäki A, Ueki K, Kahn CR. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 1999, 103:931-943.
65. Bickel PE. Lipid rafts and insulin signaling. Am J Physiol Endocrinol Metab 2002, 282:E1-E10.
66. Inokuchi J. Insulin resistence as a membrane microdomain disorder. Biol Pharm Bull 2006, 29:1532-1537.
67. Manes S, del Real G, Lacalle RA. Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep 2000, 1:190-196.
68. Parton RG, Lindsay M. Exploitation of major histocompatibility complex class I molecules and caveolae by simian virus 40. Immunol Rev 1999, 168:23-31.
69. Zhang J, Pekosz A, Lamb RA. Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins. J Virol 2000, 74:4634-4644.
70. Brugger B, Glass B, Haberkant P, Leibrecht I, Wieland FT, Kräusslich HG. The HIV lipidome: a raft with an unusual composition. Proc Natl Acad Sci USA 2006, 103:2641-2646.
71. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961, 25:585-621.
72. Magalhaes JP. From cells to ageing: a review of models and mechanisms of cellular senescence and their impact on human ageing. Exp Cell Res 2004, 300:1-10.
73. Campisi J. Replicative senescence: an old lives' tale? Cell 1996, 84:497-500.
74. Cho KA, Ryu SJ, Park JS. Senescent phenotype can be reversed by reduction of caveolin status. J Biol Chem 2003, 278:27789-27795.
75. Cho KA, Ryu SJ, Oh YS. Morphological adjustment of senescent cells by modulating caveolin-1 status. J Biol Chem 2004, 279:42270-42278.
76. Engelman JA, Chu C, Lin A. Caveolin-mediated regulation of signalling along the p42/44 MAP kinase cascade in vivo. FEBS Lett 1998, 428:205-211.
77. Wary KK, Mariotti A, Zurzolo C, Giancotti FG. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 1988, 94:625-634.
78. Wheaton K, Sampsel K, Boisvert F-M, Davy A, Robbins S, Riabowol K. Loss of functional caveolae during senescence of human fibroblasts. J Cell Physiol 2001, 187:226-235.
79. Pawelec G, Hirokawa K, Fülöp T. Altered T cell signalling in ageing. Mech Ageing Dev 2001, 122:1613-1637.
80. Fülöp T, Larbi A, Dupuis G, Pawelec G. Ageing, autoimmunity and arthritis: perturbations of TCR signal transduction pathways with ageing - a biochemical paradigm for the ageing immune system. Arthritis Res Ther 2003, 5:290-302.
81. Tamura T, Kunimatsu T, Yee S-T. Molecular mechanism of the impairment in activation signal transduction in CD4+ T cells from old mice. Int Immunol 2000, 12:1205-1215.
82. Huang Y, Wange RL. T cell receptor signaling: beyond complex complexes. J Biol Chem 2004, 279:28827-28830.
83. Utsuyama M, Wakikawa A, Tamura T, Nariuchi H, Hirokawa K. Impairment of signal transduction in T cells from old mice. Mech Ageing Dev 1997, 93:131-144.
84. Miller RA, Garcia G, Kirk CJ, Witkowski JM. Early activation defects in T lymphocytes from aged mice. Immunol Rev 1997, 160:79-90.
85. Alonso MA, Millan J. The role of lipid rafts in signalling and membrane trafficking in T lymphocytes. J Cell Sci 2001, 114:3957-3965.
86. Mustelin T, Tasken K. Positive and negative regulation in T-cell activation through kinases and phosphatases. Biochem J 2003, 371:15-27.
87. Zhang W, Sloan-Lancaster J, Kitchen L, Trible RP, Samelson LE. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 1998, 92:83-92.
88. Okada M, Nada S, Yamanashi Y, Yamamoto T, Nakagawa H. CSK: a protein- tyrosine kinase involved in regulation of src family kinases. J Biol Chem 1991, 266:24249-24252.
89. Brdicka T, Pavlistova D, Leo A. Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation. J Exp Med 2000, 191:1591-1604.
90. Kawabuchi M, Satomi Y, Takao T. Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature 2000, 404:999-1003.
91. Yasuda K, Nagafuku M, Shima T. Cutting edge: Fyn is essential for tyrosine phosphorylation of Csk-binding protein/phosphoprotein associated with glycolipid-enriched microdomains in lipid rafts in resting T cells. J Immunol 2002, 169:2813-2817.
92. Hermiston ML, Xu Z, Majeti R, Weiss A. Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases. J Clin Invest 2002, 109:9-14.
93. Davidson D, Bakinowski M, Thomas ML, Horejsi V, Veillette A. Phosphorylation-dependent regulation of T-cell activation by PAG/Cbp, a lipid raft-associated transmembrane adaptor. Mol Cell Biol 2003, 23:2017-2028.
94. Larbi A, Dupuis G, Khalil A, Douziech N, Fortin C, Fülöp T. Differential role of lipid rafts in the functions of CD4+ and CD8+ human T lymphocytes with aging. Cell Signal 2006, 18:1017-1030.
95. Fülöp T, Gagne D, Goulet A-C. Age-related impairment of p56lck and ZAP-70 activities in human T lymphocytes activated through the TcR/CD3 complex. Exp Gerontol 1999, 34:197-216.
96. Whisler RL, Bagenstose SE, Newhouse YG, Carle KW. Expression and catalytic activities of protein tyrosine kinases (PTKs) Fyn and Lck in peripheral blood T cells from elderly humans stimulated through the T cell receptor (TCR)/CD3 complex. Mech Ageing Dev 1997, 98:57-73.
97. Inomata M, Shimada Y, Hayashi M, Shimizu J, Ohno-Iwashita Y. Impairment in a negative regulatory system for TCR signaling in CD4+ T cells from old mice. FEBS Lett 2007, 581:3039-3043.
98. Brdickova N, Brdicka T, Andera L. Interaction between two adapter proteins, PAG and EBP50: a possible link between membrane rafts and actin cytoskeleton. FEBS Lett 2001, 507:133-136.
99. Jordan S, Rodgers W. T cell glycolipid-enrichhed membrane domains are constitutively assembled as membrane patches that translocate to immune synapses. J Immunol 2003, 171:78-87.
100. Vallejo AN, Nestel AR, Schirmer M, Weyand CM, Goronzy JJ. Aging-related deficiency of CD28 expression in CD4+ T cells is associated with the loss of gene-specific nuclear factor binding activity. J Biol Chem 1998, 273:8119-8129.
101. Tavano R, Contento RL, Baranda SJ. CD28 interaction with filamin-A controls lipid raft accumulation at the T-cell immunological synapse. Nat Cell Biol 2006, 8:1270-1276.